Antibiotic Treatment Guidelines

Introduction to Antibiotic Treatment

The Infectious Diseases Society of America (IDSA) and other guideline societies recommend selecting antibiotics based on the severity of the infection, suspected pathogen resistance patterns, and patient factors such as age, pregnancy, and renal function 1, 2, 3
The IDSA recommends identifying the likely pathogen based on infection site and clinical presentation, considering local resistance patterns, selecting the narrowest spectrum agent effective against the suspected pathogen, adjusting for patient factors, optimizing dosing based on pharmacokinetic/pharmacodynamic principles, reassessing therapy at 48-72 hours based on clinical response and culture results, de-escalating to targeted therapy when possible, and continuing for the appropriate duration based on infection type and clinical response 4, 5, 6

The IDSA recommends dicloxacillin, cephalexin, or amoxicillin-clavulanate as first-line treatment for impetigo or cellulitis, with alternative options for MRSA suspected cases including TMP-SMX, doxycycline, or linezolid 7
For necrotizing fasciitis, combination therapy with vancomycin or linezolid plus piperacillin-tazobactam or a carbapenem is recommended 7
The treatment duration for most skin infections is 7-14 days, with uncomplicated skin infections typically requiring 7-10 days of treatment and complicated skin infections requiring 7-14 days, as recommended by the IDSA 1
Doxycycline is effective against many skin pathogens, including staphylococci, streptococci, and anaerobes, as reported by the IDSA 1
Beta-lactam antibiotics targeting Staphylococcus aureus and Streptococcus species are recommended as first-line treatment, with specific antibiotic selection based on infection severity and suspected pathogen resistance patterns 1, 2

For community-acquired pneumonia, levofloxacin 750 mg daily or ceftriaxone plus azithromycin are recommended for inpatient treatment 4
For hospital-acquired pneumonia, an anti-pseudomonal β-lactam plus an aminoglycoside or fluoroquinolone is recommended 4
For atypical pneumonia, doxycycline 100 mg bid or azithromycin 500 mg day 1, then 250 mg daily are recommended for Mycoplasma or Chlamydophila infections, while levofloxacin 750 mg daily or azithromycin are recommended for Legionella infections 4
The IDSA recommends the following durations for antibiotic treatment:
- Respiratory infections: 5-7 days
- Skin and soft tissue infections: 5-10 days
- Urinary tract infections: 3-7 days
- Bloodstream infections: 7-14 days (7 days for uncomplicated)
- Bone/joint infections: ≥4-6 weeks
- Endocarditis: 4-6 weeks 5, 6

The Centers for Disease Control and Prevention recommends ceftriaxone 250 mg IM single dose for gonorrhea treatment 8
For chlamydia treatment, azithromycin 1 g PO single dose or doxycycline 100 mg bid for 7 days are recommended 8

The following antibiotics have specific dosages:

Antibiotic	Dosage	Population	Indication
Metronidazole	300-450 mg PO three times daily or 600 mg IV every 8 hours	Adults	Anaerobic infections [1]
Vancomycin	1-2 g IV every 8 hours	Adults	MRSA infections, VRE infections, and complicated skin infections [9]
Clindamycin	10-20 mg/kg/day PO in 3 divided doses or 25-40 mg/kg/day IV in 3 divided doses	Children	Skin and soft tissue infections, with contraindications including history of C. difficile infection [3]
Amoxicillin-clavulanate	875/125 mg PO every 12 hours or 500/125 mg PO every 8 hours for 7-14 days	Adults and children	Skin and soft tissue infections, respiratory tract infections, otitis media, and animal and human bites [1, 10]
Ceftriaxone	1-2 g IV every 24 hours for 7-14 days	Adults and children	Severe community-acquired pneumonia, meningitis, complicated urinary tract infections, gonorrhea, and severe skin and soft tissue infections [1, 2]

Oxacillin and nafcillin are recommended for MSSA infections, with a dosage of 2 g IV q4-6h 1
Cefazolin is recommended for MSSA, streptococci, and some Gram-negative bacilli, with a dosage of 2 g IV q8h 1
Vancomycin is recommended for Gram-positive organisms including MRSA, with a dosage of 15-20 mg/kg IV q8-12h 1, 4
Clindamycin is recommended for Gram-positive cocci and anaerobes, with a dosage of 600 mg IV/PO q8h 1
Linezolid is recommended for MRSA, VRE, and resistant pneumococci, with a dosage of 600 mg PO/IV q12h 4

Doxycycline is contraindicated in pregnancy, especially after the first trimester, due to the risk of teratogenicity, as stated by the American Academy of Family Physicians 11
Doxycycline is not recommended for children under 8 years due to the risk of dental staining 3
Tetracyclines are rarely used in children younger than 8 years of age and are contraindicated in pregnancy due to potential teratogenicity 3
Fluoroquinolones are generally contraindicated in children and adolescents under 18 years and in pregnancy due to potential teratogenicity 3

The American Academy of Family Physicians suggests documenting infection parameters to enable treatment assessment, and using clinical diagnostic criteria rather than broad-spectrum antibiotics as a substitute for accurate diagnosis 12
The Centers for Disease Control and Prevention suggests obtaining appropriate cultures before starting antibiotics when possible and regularly auditing antibiotic prescribing patterns 12
The World Health Organization recommends using the shortest effective duration to minimize resistance development and streamlining therapy as soon as culture results become available 7